Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06034548 · ClinicalTrials.gov registry record · NA
Diabetes and Hypertension Self Management Program
A NA study, sponsored by West Virginia University.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT06034548: Completed NA study, sponsored by West Virginia University.
NCT06034548 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06034548, a NA study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this R15 project is to test the feasibility and effectiveness of a 12-week diabetes and hypertension self-management program using trained health coaches.
Primary Outcome
The difference in A1c between baseline and end of program.
Interventions
- BEHAVIORAL diabetes and hypertension self-management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-08-27 |
| Est. Completion | 2020-08-12 |
| Phase | NA |
What the finished NCT06034548 record still lists
NCT06034548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which diabetes and hypertension self-management is the first listed.
NCT06034548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06034548 about?
NCT06034548 is a clinical study titled "Diabetes and Hypertension Self Management Program". The purpose of this R15 project is to test the feasibility and effectiveness of a 12-week diabetes and hypertension self-management program using trained health coaches.
What is the current status of trial NCT06034548?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2018-08-27. Estimated completion is 2020-08-12.
What interventions are being tested in trial NCT06034548?
The interventions under investigation include: diabetes and hypertension self-management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06034548?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06034548's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI